Novo CEO pressed by Senate to cut selling prices of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would look at new talks with insurers concerning the listing prices of Wegovy and copyright when they pledge to maintain the medicines on their formularies. This prepare aligns https://daltonkiged.blogacep.com/35860569/not-known-facts-about-healthcare-news